Thesis: "Efficacy of Interleukin-6 receptor inhibitors versus conventional DMARDs in the treatment of Polymyalgia Rheumatica: A multi-centre retrospective study"
Scientific supervisor: Univ.-Prof. Dr. med. Christian Dejaco
Clinical Rotation
Hospital of Bruneck (Südtiroler Sanitätsbetrieb)
03.2024 - 12.2024
Focused training in giant cell arteritis and polymyalgia rheumatica under the supervision of Univ.-Prof. Dr. med. Christian Dejaco
Ausbildung
Medical Degree -
University of Florenz
2014 - 2020
Erasmus+ traineeship -
Medizinische Universität Innsbruck
09.2018 - 01.2020
Kompetenzen
MSK ultrasound in rheumatologic diagnostics
Hands-on experience in intra-articular injections and synovial biopsies
Practical skills in microscopic analysis of synovial fluid
Performance of capillaroscopy
Use and interpretation of bone mineral density tests (DEXA)
Publications
Garaffoni C, Tamussin M, Calciolari I, Lanza G, Bortoluzzi A, Scirè CA, Govoni M, Silvagni E. High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study. Front Immunol. 2024 Jan 11;14:1298583.
Bracalenti M, Zen M, Bianchi B, Bortoluzzi A, Brussino L, Castrignanò P, Cauli A, Cavagna L, Chessa E, Chiara E, De Angelis R, De Marchi G, Di Carlo M, Emmi G, Galvagni I, Gasparotto M, Gatto M, Gerli R, Govoni M, Lo Gullo A, Nano A, Negrini S, Noviello S, Orsolini G, Pazzola G, Piga M, Quartuccio L, Rossini M, Salvarani C, Silvagni E, Silvestri E, Tamussin M, Tizian M, Tomietto P, Urban ML, Vacca A, Doria A, Iaccarino L. Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0). Biologics. 2025 Oct 30;19:651-663. doi: 10.2147/BTT.S536660. PMID: 41190171; PMCID: PMC12581791.
Zertifizierung
Good Clinical Practice (GCP) Certificate – August 2025
Practical course on biopsy techniques for the histopathological diagnosis of rheumatic diseases – June 2025, Siena (Italy)
Campus SIR Young - June 2025, Lazise (Italy)
EULAR Basic Course in Musculoskeletal Ultrasound – October 2024, Torino (Italy)
Clinical Trials Involvement as Subinvestigator
SIRIUS-SLE 2 – Ianalumab in systemic lupus erythematosus (NCT05313014)
LAVENDER – Anifrolumab in cutaneous lupus erythematosus (NCT06015737)
FILOSOPHY – Filgotinib in rheumatoid arthritis (NCT04871919)
PRECISE – Identification of synovial biomarkers of response to ixekizumab in refractory psoriatic arthritis
MATRIX - Evaluation of in vitro synovial functional response profiling for precision medicine in chronic inflammatory arthritis
MATRIX-IIS UPA - Selective JAK inhibition at synovial level: unveiling the effect of upadacitinib in refractory rheumatoid arthritis. a pilot in vitro study